Cerity Partners LLC Raises Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Cerity Partners LLC grew its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 3.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,666 shares of the company’s stock after purchasing an additional 132 shares during the period. Cerity Partners LLC’s holdings in Prestige Consumer Healthcare were worth $315,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. GAMMA Investing LLC raised its stake in Prestige Consumer Healthcare by 35.9% in the 1st quarter. GAMMA Investing LLC now owns 1,879 shares of the company’s stock worth $162,000 after acquiring an additional 496 shares during the last quarter. KBC Group NV raised its stake in Prestige Consumer Healthcare by 7.4% in the 1st quarter. KBC Group NV now owns 2,199 shares of the company’s stock worth $189,000 after acquiring an additional 151 shares during the last quarter. QRG Capital Management Inc. raised its stake in Prestige Consumer Healthcare by 8.6% in the 1st quarter. QRG Capital Management Inc. now owns 5,971 shares of the company’s stock worth $513,000 after acquiring an additional 475 shares during the last quarter. Norges Bank purchased a new position in Prestige Consumer Healthcare in the 4th quarter worth $40,009,000. Finally, BNP Paribas Financial Markets grew its position in Prestige Consumer Healthcare by 1,073.3% during the 4th quarter. BNP Paribas Financial Markets now owns 203,903 shares of the company’s stock worth $15,923,000 after purchasing an additional 186,524 shares during the period. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Prestige Consumer Healthcare Price Performance

NYSE:PBH opened at $76.77 on Monday. Prestige Consumer Healthcare Inc. has a 52 week low of $64.94 and a 52 week high of $90.04. The company has a quick ratio of 2.82, a current ratio of 4.20 and a debt-to-equity ratio of 0.55. The stock has a market capitalization of $3.79 billion, a PE ratio of 17.90, a price-to-earnings-growth ratio of 2.31 and a beta of 0.43. The stock’s 50-day moving average price is $81.81 and its 200-day moving average price is $82.37.

Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Thursday, May 8th. The company reported $1.32 EPS for the quarter, beating analysts’ consensus estimates of $1.30 by $0.02. Prestige Consumer Healthcare had a return on equity of 12.87% and a net margin of 18.86%. The firm had revenue of $296.52 million for the quarter, compared to analysts’ expectations of $289.36 million. During the same period last year, the firm earned $1.02 EPS. The company’s quarterly revenue was up 7.0% on a year-over-year basis. As a group, equities analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on PBH shares. Wall Street Zen raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, July 5th. Royal Bank Of Canada raised Prestige Consumer Healthcare to a “hold” rating in a research report on Thursday, May 8th. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, Prestige Consumer Healthcare has an average rating of “Moderate Buy” and a consensus price target of $93.33.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.